1. Home
  2. RVPH vs GLBS Comparison

RVPH vs GLBS Comparison

Compare RVPH & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • GLBS
  • Stock Information
  • Founded
  • RVPH 2006
  • GLBS 2006
  • Country
  • RVPH United States
  • GLBS Greece
  • Employees
  • RVPH N/A
  • GLBS N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • GLBS Marine Transportation
  • Sector
  • RVPH Health Care
  • GLBS Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • RVPH 26.6M
  • GLBS 23.4M
  • IPO Year
  • RVPH N/A
  • GLBS 2007
  • Fundamental
  • Price
  • RVPH $0.47
  • GLBS $1.11
  • Analyst Decision
  • RVPH Strong Buy
  • GLBS Strong Buy
  • Analyst Count
  • RVPH 5
  • GLBS 1
  • Target Price
  • RVPH $9.00
  • GLBS $3.00
  • AVG Volume (30 Days)
  • RVPH 3.4M
  • GLBS 24.9K
  • Earning Date
  • RVPH 08-13-2025
  • GLBS 09-11-2025
  • Dividend Yield
  • RVPH N/A
  • GLBS N/A
  • EPS Growth
  • RVPH N/A
  • GLBS N/A
  • EPS
  • RVPH N/A
  • GLBS N/A
  • Revenue
  • RVPH N/A
  • GLBS $35,776,000.00
  • Revenue This Year
  • RVPH N/A
  • GLBS $5.01
  • Revenue Next Year
  • RVPH N/A
  • GLBS $27.86
  • P/E Ratio
  • RVPH N/A
  • GLBS N/A
  • Revenue Growth
  • RVPH N/A
  • GLBS 17.92
  • 52 Week Low
  • RVPH $0.30
  • GLBS $0.99
  • 52 Week High
  • RVPH $4.28
  • GLBS $2.21
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 47.70
  • GLBS 44.17
  • Support Level
  • RVPH $0.38
  • GLBS $1.10
  • Resistance Level
  • RVPH $0.45
  • GLBS $1.23
  • Average True Range (ATR)
  • RVPH 0.03
  • GLBS 0.06
  • MACD
  • RVPH 0.02
  • GLBS -0.00
  • Stochastic Oscillator
  • RVPH 93.07
  • GLBS 12.50

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: